Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mechanistic insights into EGFR-Targeted: [¹²⁵I]I-rociletinib as a model small-molecule radioligand.

Tissue & cell·2026

Same author

Preparation and Evaluation of Radiolabeled Porphyrin-Functionalized Lipid Nanodroplets for Cancer Theranostics.

Molecules (Basel, Switzerland)·2026

Same author

[A New Frontier in Cancer Therapy: Exploring the Potential of At-211].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026

Same author

[Development and Evaluation of At-211 Labeled Peptides].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026

Same author

Synthesis and Evaluation of Radiogallium-Labeled Peptide Probes for In Vivo Imaging of Legumain Activity.

Molecules (Basel, Switzerland)·2025

Same author

Ultrafast time-resolved observation of non-thermal current-induced switching in an antiferromagnetic Weyl semimetal.

Nature materials·2025

Same journal

An Improved Brain-Penetrating Nanoformulation of the VIPR2 Antagonist Peptide KS-133 for Treating Cognitive Impairment in Schizophrenia.

Biological & pharmaceutical bulletin·2026

Same journal

A Quantitative in Vitro Framework Reveals State-Dependent Pharmacological Responses to Repeated Inflammatory Stimulation in Synovial Fibroblasts.

Biological & pharmaceutical bulletin·2026

Same journal

Pinolenic Acid Inhibits Prostanoid TP Receptor-Mediated Contraction in Porcine Coronary Arteries.

Biological & pharmaceutical bulletin·2026

Same journal

Lipopolysaccharide-Induced Changes in Facial Expression and Orofacial Movement in Mice.

Biological & pharmaceutical bulletin·2026

Same journal

Enhancing the Norepinephrine Transporter Expression and [<sup>211</sup>At]MABG Uptake with Vorinostat Preloading in the Pheochromocytoma Model.

Biological & pharmaceutical bulletin·2026

Same journal

Sterility Test Conditions for Purified Sodium Hyaluronate Injection Evaluated via Membrane Filtration.

Biological & pharmaceutical bulletin·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 9, 2025

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

Probes with Tailored Pharmacokinetics for Radiotheranostics.

Masayuki Munekane¹, Hiroaki Echigo¹, Takeshi Fuchigami¹

¹Graduate School of Medical Sciences, Kanazawa University.

Biological & Pharmaceutical Bulletin

|August 31, 2025

Summary

This summary is machine-generated.

Radiotheranostics, using radioisotopes for cancer diagnosis and therapy, requires optimized probe design. This review details strategies like multimerization and albumin-binding to improve probe targeting and effectiveness.

Keywords:

Auger electron therapy personalized medicine radiotheranostics subcellular localization targeted alpha therapy

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

Related Experiment Videos

Last Updated: Sep 9, 2025

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

Area of Science:

Oncology
Radiochemistry
Molecular Imaging

Background:

Radiotheranostics, combining radioisotopes for diagnosis and therapy, is a rapidly advancing field in oncology.
Effective radiotheranostic agents depend on precisely designed probes for targeted delivery.
Probe design is critical for optimizing pharmacokinetics and subcellular localization.

Purpose of the Study:

To review fundamental concepts and recent advancements in probe design for radiotheranostics.
To highlight strategies for optimizing probe performance in diagnostic and therapeutic applications.
To explore novel design possibilities for radiotheranostic probes.

Main Methods:

Review of established and emerging probe design strategies.
Analysis of pharmacokinetic and subcellular localization factors.
Discussion of specific design modifications including multimerization, albumin-binding, charge modification, glycosylation, cell-penetrating peptides, covalent binding, nuclear targeting, and drug release.

Main Results:

Various strategies significantly impact probe pharmacokinetics and subcellular localization.
Multimerization, albumin-binding, and charge modification enhance targeting and retention.
Cell-penetrating peptides, nuclear targeting, and controlled drug release offer advanced control over agent behavior.

Conclusions:

Optimized probe design is essential for successful radiotheranostics.
Multiple strategies can be employed to fine-tune probe behavior for improved efficacy.
Further research into novel probe designs will advance the field of radiotheranostics.